This week, Grady examines the key drivers of market activity: the latest quarterly updates, ongoing global trade tensions, and the trajectory of China’s economic recovery. Plus, hear insights from Bell Potter healthcare analyst John Hester, who yesterday discussed the potential impact of pending pharmaceutical tariffs on Australian listed healthcare companies.

In this week’s wrap, Grady covers:

• (0:32): why WiseTech (ASX:WTC) declined on Tuesday
• (1:00): exclusive addition - Bell Potter’s view on Trump’s healthcare tariffs
• (3:48): Westpac (ASX:WBC) & NAB (ASX:NAB) 1H results
• (4:33): the latest on the US – China trade talks
• (5:56): how the ASX200 performed this week so far
• (6:28): the most traded stocks & ETFs by Bell Direct clients
• (6:56): economic news items to watch out for.